You are here
Hawaii Biotech, Inc.
UEI: ECJKEEFL4L51
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Optimization of Small Molecule Botulinum Neurotoxin Inhibitors
Amount: $1,019,210.00DESCRIPTION (provided by applicant): Medicinal and computational chemistry methods will be used to optimize validated hit compounds found to inhibit botulinum neurotoxin. These inhibitors, discovered ...
SBIRPhase I2006Department of Health and Human Services National Institutes of Health -
Recombinant Subunit Protein for Flu Vaccine
Amount: $979,908.00DESCRIPTION (provided by applicant): Current influenza vaccine production procedures (use of embryonated chicken eggs) inherently limit the amount of influenza vaccine that can be produced prior to e ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health -
Recombinant Subunit Vaccine/Prevention of West Nile Vir*
Amount: $5,046,580.00DESCRIPTION (provided by applicant): West Nile virus infection is an emerging infectious disease in the United States. The virus infects birds, which serve as the natural reservoir for the virus, in a ...
SBIRPhase II2004Department of Health and Human Services National Institutes of Health -
Recombinant Subunit Vaccine for Tick-Borne Encephalitis
Amount: $422,170.00DESCRIPTION (provided by applicant): Tick-borne encephalitis (TBE) is a neurological disease caused by Flaviviruses of the tick-borne encephalitis group and causes death in up to 60% of the individua ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
Development of a Subunit Vaccine for West Nile
Amount: $189,420.00DESCRIPTION (provided by applicant): West Nile virus infection has become an emerging infectious disease in the United States. The virus infects birds, the natural reservoir of the virus, and is tran ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
INHIBITORS OF ANTHRAX LETHAL FACTOR METALLOPROTEINASE
Amount: $295,510.00DESCRIPTION (provided by applicant): This proposal outlines a novel approach towards the development of a therapeutic agent to treat anthrax infection by inhibiting the intracellular actions of letha ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
EVALUATION OF IMMUNOGENICITY: MALARIA SUBUNIT VACCINE
Amount: $129,871.00Malaria is a tropical parasitic disease that poses a significant health threat to much of the world. Each year, approximately 500 million become infected and more them 2 million die. There is great ne ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
SELECTIVE ACTIVATION OF ANTIFUNGAL PRODRUGS
Amount: $299,488.00DESCRIPTION (Provided by applicant): The proposed research will investigate the feasibility of utilizing inherent properties of the infection site as a means to activate antifungal prodrugs selectivel ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
Viability Assay for Foodborne Bacterial Pathogens
Amount: $70,000.00There are an estimated 76 million cases of foodborne illness in the United States annually, resulting in 325,000 hospitalizations and 5,000 deaths. The financial impact has been estimated at $35 billi ...
SBIRPhase I2001Department of Agriculture -
Development of a MSP1-p42 Subunit Vaccine for Malaria
Amount: $0.00DESCRIPTION (provided by the applicant): Malaria is a tropical parasitic disease that poses a significant health threat to much of the world. Each year, approximately 500 million peop ...
SBIRPhase I2001Department of Health and Human Services National Institutes of Health
